<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01792973</url>
  </required_header>
  <id_info>
    <org_study_id>PapilloV</org_study_id>
    <nct_id>NCT01792973</nct_id>
  </id_info>
  <brief_title>HPV Infection and Cervical Lesions in HIV Infected Women in Thailand: A Prospective Study</brief_title>
  <acronym>PapilloV</acronym>
  <official_title>HPV Infection and Cervical Lesions in HIV Infected Women in Thailand</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Recherche pour le Developpement</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fondation de France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut de Recherche pour le Developpement</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      HIV-infected women are at high risk of developing cervical cancer. This is a 3-year cohort
      study nested in the already existing Program for HIV Prevention and Treatment (PHPT) cohort
      of HIV-infected patients in Thailand (NCT 00433030). The main objective is to assess the
      prevalence, incidence, and clearance rate of HPV cervical infection and associated cervical
      lesion. The study will also provide the distribution of the HPV genotypes involved as well as
      other risk factors of cervical lesions. HIV-infected women receiving antiretrovirals, older
      than18 years of age, followed in the PHPT cohort or in the same hospitals are proposed to
      participate. An annual gynecological examination with a Pap-smear and a sampling for HPV
      testing is performed. Women with abnormal Pap-smear or with High-Risk HPV (HR-HPV) infection
      receive a more intensive follow-up with a colposcopy and a biopsy if necessary. Treatment is
      provided according to the National Guidelines.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Title of the study: HPV Infection and Cervical Lesions in HIV infected Thai Women - A
      Prospective Study Country: Thailand Study period: 3 years Planned enrollment duration: 6
      months

      Primary objectives:

        1. To evaluate the prevalence, the incidence, the persistence rate and the clearance rate
           of HPV cervical infection, of genotypes involved and of multiple infections.

        2. To evaluate the prevalence, the incidence, the progression rate and the regression rate
           of cyto-histological abnormalities

        3. To assess the efficacy of different screening algorithms using pap smear alone,
           pap-smear associated with HPV and HPV alone

      Secondary objectives:

        1. To determine the risk factors of high grade lesions (Cervical intraepithelial neoplasia
           (CIN)2 or higher) in HIV infected Thai women

        2. To evaluate cyto-histology performances at different hospital levels Methods: A
           multicenter prospective cohort study nested in the PHPT cohort.

      Inclusion criteria: HIV infected women, older than18 years of age, followed in the PHPT
      cohort or in the same hospitals.

      Exclusion criteria: Virginity, total hysterectomy, pregnancy after 3rd month, inclusion in a
      HPV vaccination trial Planned number of patients to be enrolled: 884

      Follow-up procedures:

      Annual gynecological examination with a Pap-smear and a sampling for HPV testing is planned.

      Women with abnormal Pap-smear or with High-Risk HPV (HR-HPV) infection will be referred to a
      colposcopist.

      In case of abnormalities at the colposcopy, a biopsy will be performed.

        -  If the biopsy is normal or shows a CIN1, the women will be referred for a new
           colposcopic examination 6 months later.

        -  If the biopsy shows CIN2 or more, treatment will be provided -LEEP or conisation, or
           hysterectomy, and the women will be referred for a new colposcopic examination 6 months
           later.

      Biological and pathological procedures:

        -  Pap-smears will be read by local pathologists in participating hospital.

        -  Biopsies will be read by local pathologists in participating hospital.

        -  HPV tests will all be performed in the PHPT virological laboratory in Chiang Mai.

      Statistical methodology:

      Descriptive statistics, univariate and multivariate analyses.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2012</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>High risk HPV infection</measure>
    <time_frame>January 2015</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cervical lesions: cytological abnormalities of squamous cells: ASC-US, ASC-H, LSIL, HSIL or SCC (ASCUS +) or glandular cells (AGC, AGC favor neoplasia or adenocarcinoma)</measure>
    <time_frame>Up to 3 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">829</enrollment>
  <condition>Cervical Cancer</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cervical secretions
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-infected women followed in the PHPT cohort
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV infected women, older than 18 years of age, followed in the PHPT cohort

        Exclusion Criteria:

          -  Virginity, total hysterectomy, pregnancy after 3rd month, inclusion in a HPV
             vaccination trial
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sophie Le Coeur, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut National d'Etudes Démographiques</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gonzague Jourdain, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Recherche pour le Developpement</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nicole Ngo-Giang- Huong, PharmaD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de Recherche pour le Developpement</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Isabelle Heard, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre national de réference des papillomavirus humains, Institut Pasteur</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aram Limtrakul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nakornping Hospital, Minsitry of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nantasak Chotivanich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chonburi Hospital, Minsitry of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Chaiwat Putiyanun, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chiang Kham Hospital, Ministry of Public Health</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Samreung Rangdaeng, Associate professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Pathology Faculty of Medicine, Chiang Mai University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bhumibol Adulyadej Hospital</name>
      <address>
        <city>Saimai</city>
        <state>Bangkok</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prapokklao Hospital</name>
      <address>
        <city>Prapokklao, Muang</city>
        <state>Chantaburi</state>
        <zip>22000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakornping Hospital</name>
      <address>
        <city>Mae Rim</city>
        <state>Chiang Mai</state>
        <zip>50180</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lamphun Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chiang Mai</state>
        <zip>51000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanpatong Hospital</name>
      <address>
        <city>Sanpatong</city>
        <state>Chiang Mai</state>
        <zip>20120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mae Chan Hospital</name>
      <address>
        <city>Mae Chan</city>
        <state>Chiang Rai</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mae Sai Hospital</name>
      <address>
        <city>Mae Sai</city>
        <state>Chiang Rai</state>
        <zip>57130</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phan Hospital</name>
      <address>
        <city>Phan</city>
        <state>Chiang Rai</state>
        <zip>57120</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiangrai Prachanukroh Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chiangrai</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chonburi Hospital</name>
      <address>
        <city>Muang</city>
        <state>Chonburi</state>
        <zip>20000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lampang Hospital</name>
      <address>
        <city>Muang</city>
        <state>Lampang</state>
        <zip>52000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mahasarakam Hospital</name>
      <address>
        <city>Muang</city>
        <state>Mahasarakam</state>
        <zip>44000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nakhonpathom Hospital</name>
      <address>
        <city>Muang</city>
        <state>Nakhonpathom</state>
        <zip>73000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nong Khai Hospital</name>
      <address>
        <city>Muang</city>
        <state>Nong Khai</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chiang Kham Hospital</name>
      <address>
        <city>Chiang Kham</city>
        <state>Phayao</state>
        <zip>56110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buddhachinaraj Hospital</name>
      <address>
        <city>Muang</city>
        <state>Pitsanulok</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ratchaburi Hospital</name>
      <address>
        <city>Muang</city>
        <state>Ratchaburi</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rayong Hospital</name>
      <address>
        <city>Muang</city>
        <state>Rayong</state>
        <zip>21000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samutprakarn Hospital</name>
      <address>
        <city>Pak Nam</city>
        <state>Samutprakarn</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samutsakorn Hospital</name>
      <address>
        <city>Muang</city>
        <state>Samutsakorn</state>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hat Yai Hospital</name>
      <address>
        <city>Hat Yai</city>
        <state>Songkla</state>
        <zip>90110</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bhuddasothorn Hospital</name>
      <address>
        <city>Chachoengsao</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maharat Nakhon Ratchasima Hospital</name>
      <address>
        <city>Nakhonratchasima</city>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Phayao Hospital</name>
      <address>
        <city>Phayao</city>
        <zip>56000</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <results_reference>
    <citation>Le Coeur Sophie, Delory Tristan, Ngo-Giang-Huong Nicole, Rangdaeng Samreung, Heard Isabelle, Limtrakul Aram, Chotivanich Nantasak, Putiyanun Chaiwat, Leenasirimakul Prattana, Jourdain Gonzague. 2015. -&quot;HPV Genotypes and factors associated with HR-HPV infection in HIV-infected women on Antiretroviral Therapy (ART) in Thailand: a national cohort&quot;. 30th International Papillomavirus Conference (HPV 2015), Lisbon, Portugal. 9-11 sept. 2015.</citation>
  </results_reference>
  <results_reference>
    <citation>Delory T, Ngo-Giang-Huong N, Rangdaeng S, Chotivanich N, Limtrakul A, Putiyanun C, Suriyachai P, Matanasarawut W, Jarupanich T, Liampongsabuddhi P, Heard I, Jourdain G, Lallemant M, Le Coeur S; PapilloV study group. Human Papillomavirus infection and cervical lesions in HIV infected women on antiretroviral treatment in Thailand. J Infect. 2017 May;74(5):501-511. doi: 10.1016/j.jinf.2017.02.007. Epub 2017 Feb 28.</citation>
    <PMID>28254419</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2013</study_first_submitted>
  <study_first_submitted_qc>February 13, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 15, 2013</study_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut de Recherche pour le Developpement</investigator_affiliation>
    <investigator_full_name>Marc Lallemant</investigator_full_name>
    <investigator_title>Institut de Recherche pour le Developpement</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>HPV</keyword>
  <keyword>Women</keyword>
  <keyword>Thailand</keyword>
  <keyword>Antiretrovirals</keyword>
  <keyword>Cervical cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
    <mesh_term>Papillomavirus Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

